Safety and Efficacy of Long-Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension
2016 ◽
Vol 111
◽
pp. S262
2017 ◽
Vol 112
◽
pp. S321
2018 ◽
Vol 113
◽
pp. S3
Keyword(s):
2008 ◽
Vol 20
(3)
◽
pp. 399-401
◽
Keyword(s):
2001 ◽
Vol 33
(7)
◽
pp. 563-569
◽
Keyword(s):
2015 ◽
Vol 81
(5)
◽
pp. AB147
◽
Keyword(s):
1994 ◽
Vol 17
◽
pp. S74-S87
◽
2015 ◽
Vol 9
(suppl 1)
◽
pp. S15-S15
◽
Keyword(s):